
Frantz EyeCare reports 98% of Light Adjustable Lens patients achieved refractive accuracy within ±0.50 D of target, exceeding published national cataract surgery benchmarks.
Philadelphia-Thalidomide is dead, at least when it comes to itscurative properties for age-related macular degeneration (AMD). This isthe conclusion of the Age-Related Macular Degeneration and Thalidomide Study(AMDATS).




